|
|
|
|
Immunohistochemistry (Paraffin-embedded sections) - NCOA3 antibody [0.T.198] (ab14139)
![Immunohistochemistry (Paraffin-embedded sections) - NCOA3 antibody [0.T.198] (ab14139)](/ps/datasheet/images/ab14139_1.jpg)
(enlarge)
|
|
|
|
|
Product Name
|
KAT13B / AIB1 antibody [0.T.198]
|
| |
See all KAT13B / AIB1 antibodies (10)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Mouse monoclonal [0.T.198] to KAT13B / AIB1
|
|
Immunogen
|
Fusion protein, corresponding to amino acids 605-1294 of Human NCOA3.
|
|
Reacts with
(species key)
|
Hu
|
|
Tested applications
(see key)
|
IHC-P, IP, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions IHC-P: Use at an assay dependent dilution. IP: Use 10µl for 10500 cells. WB: 1/1000. Detects a band of approximately 150 kDa (predicted molecular weight: 170 kDa).
Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Positive control
(see definition)
|
RIPA lysates from BG-1 ovarian cancer cells.
|
|
Cellular localization
|
Mainly cytoplasmic and weakly nuclear. Upon TNF activation and subsequent phosphorylation, it translocates from the cytoplasm to the nucleus.
|
|
Research areas
|
Cancer >> Cancer Metabolism >> Metabolic signaling pathway >> Metabolism of lipids and lipoproteins Cancer >> Signal transduction >> Nuclear signaling >> Nuclear hormone receptors >> Coactivators and repressors Chromatin and Nuclear Signaling >> Chromatin Modifying Enzymes >> Acetylation >> HAT Chromatin and Nuclear Signaling >> Nuclear Signaling Pathways >> Nuclear Receptors >> Co-activators/co-repressors Signal Transduction >> Signaling Pathway >> Nuclear Signaling >> Nuclear Hormone Receptors >> Co-activators/co-repressors Tags & Cell Markers >> Cell Type Markers >> Tumor Associated
|
|
Relevance
|
KAT13B / AIB1 interacts in a ligand-dependent fashion with the estrogen receptor to enhance estrogen-dependent transcriptional gene activation. The protein encoded by this gene is a nuclear receptor coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activator functions. The encoded protein has histone acetyltransferase activity and recruits KAT3A / KAT3B as part of a multisubunit coactivation complex. This protein is initially found in the cytoplasm but is translocated into the nucleus upon phosphorylation. Two transcript variants encoding different isoforms have been found for this gene. In addition, a polymorphic repeat region is found in the C-terminus of the encoded protein.
|
|
|
KAT13B / AIB1 antibody [0.T.198] (ab14139)
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Mouse
|
|
Clonality
|
Monoclonal
|
|
Clone number
|
0.T.198
|
|
Isotype
|
IgG
|
|
Purity
|
Ascites
|
|
Storage buffer
|
Preservative: 0.05% Sodium Azide
Material safety datasheet (MSDS) for this product: Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
Concentration not determined - why is this?
|
|
Storage instructions
|
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C (add glycerol to a final volume of 50% for extra stability). Avoid repeated freeze / thaw cycles.
|
|
Notes
|
Aliquots are stable for at least 24 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this KAT13B / AIB1 antibody [0.T.198] is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
|
See below for KAT13B / AIB1 antibody [0.T.198] images, references, products related to ab14139 and other tools.
|
| |
KAT13B / AIB1 antibody [0.T.198] images:
|
Immunohistochemistry (Paraffin-embedded sections) - NCOA3 antibody [0.T.198] (ab14139)
Superficial spreading type level IV malignant melanoma from the skin of the back, with microsatellite formation, possible lymphatic vascular invasion, low mitotic rate and moderate tumor infiltrating lymphocytes. Ab14139 used at a dilution of 1:25.
|
| |
References for KAT13B / AIB1 antibody [0.T.198] (ab14139)
|
|
This product has been used in: (two most recent references)
Gould Rothberg BE et al. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 101:452-74 (2009). PubMed: 19318635
Rangel J et al. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. J Clin Oncol 24:4565-9 (2006). IHC-P; Human. PubMed: 17008696
If you publish research using ab14139 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to KAT13B / AIB1
|
| |
KAT13B / AIB1 antibody [0.T.198] - more information
|
Customer reviews (feedback) regarding KAT13B / AIB1 antibody [0.T.198] |
Customer FAQs regarding KAT13B / AIB1 antibody [0.T.198] |
Protocols for KAT13B / AIB1 antibody [0.T.198] |
Price and availability of products related to KAT13B / AIB1 antibody [0.T.198] |
| |
KAT13B / AIB1 antibody [0.T.198] - related products:
|
|
|
| |
KAT13B / AIB1 antibody [0.T.198] - other tools:
|
Contact Abcam with a Technical Enquiry about KAT13B / AIB1 antibody [0.T.198] |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"